Infections remain a significant cause of morbidity and mortality in cancer patients. The differential diagnosis for these patients is often wide, and the timely selection of the right clinical tests can have a significant impact on their survival. However, laboratory findings with current methodologies are often negative, challenging clinicians and laboratorians to continue the search for the responsible pathogen. Novel methodologies are providing increased sensitivity and rapid turnaround time to results but also challenging our interpretation of what is a clinically significant pathogen in cancer patients. This minireview provides an overview of the most common infections in cancer patients and discusses some of the challenges and opportunities for the clinical microbiologist supporting the care of cancer patients.
CITATION STYLE
Babady, N. E. (2016, November 1). Laboratory diagnosis of infections in cancer patients: Challenges and opportunities. Journal of Clinical Microbiology. American Society for Microbiology. https://doi.org/10.1128/JCM.00604-16
Mendeley helps you to discover research relevant for your work.